// App-Quantinova.ai

191 : How does Non-Compliance to Prolia (Denosumab) Affect the Change in Bone Mineral Density (BMD)?

Researchers

Presenter

  • M. Wong-Pack

Principal Investigators

  • A. Kalani

  • J. Hordyk

  • G. Ioannidis

  • R. Bensen

  • W.G. Bensen

  • J.D. Adachi

  • A.N. Lau

Medical Centers

  • University of Ottawa, Brampton,Canada

  • Division of Rheumatology, St. Josephs Hospital, McMaster University, Hamilton, ON, Canada

  • St. Josephs Hospital, McMaster University, Hamilton, ON, Canada

  • McMaster University, Hamilton, ON, Canada

  • Rheumatology Health Team, St Josephs Hospital , McMaster University , Hamilton,Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Bone Mineral Density

Drug/Treatment

  • Denosumab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved